New diabetes clinical trial: Rebalancing the Fat Content of the Heart and Muscles
Published on: July 14, 2025 at 11:00PM
Conditions: Diabetes Mellitus Type 2
Interventions: Drug: Semaglutide administration plus dietary counselling and physical activity encouragement; Drug: Semaglutide plus a personalised and supervised program of resistance and endurance training
Sponsors: University of Aberdeen; NHS Grampian
Not yet recruiting
https://ift.tt/5DEFh82
Conditions: Diabetes Mellitus Type 2
Interventions: Drug: Semaglutide administration plus dietary counselling and physical activity encouragement; Drug: Semaglutide plus a personalised and supervised program of resistance and endurance training
Sponsors: University of Aberdeen; NHS Grampian
Not yet recruiting
https://ift.tt/5DEFh82
Comments
Post a Comment